chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient who received in 2020 1st dose wants to get the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 17-MAY-2022 Reporter's comment: Registered pharmacist reported that a patient who received in 2020 first dose of Shingrix, wanted to get the second dose. It had been more than 6 months between doses so patient wanted to know if she could get second dose or what to do. The reporter accidentally forgot to ask for consent. The patient initials were not provided by health care professional. Lot number and expiration date of first dose was not provided by health care professional since health care professional stated this patient did not receive first dose at the same facilities. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Following standard 2 month immunizations child had high pitched crying for greater than 3 hour, also fever  101.4 axillary, pallor, no breathing problems.
Onset 6pm; jerking movements, upper body and arms with a staring look in his eyes. Physician paged 7:25pm.
R posterior shoulder pain, starting immediately after the immunization and persisting for the past 3.5 months. No loss of function in arm, no numbness or tingling; normal strength in arm. Pain is worse when she leans on or rotates her arm. No fevers, no swelling or any visible deformities.
Injection site swollen, hurt the day after. By Sunday he was really sore and started vomiting and nauseated.
I started to feel ill with a fever on Friday June 3, 2022. I took a home COVID-19 test on Monday June 6, 2022 that came up positive. I called my doctor and had a telehealth visit. She prescribed PAXLOVID that I started taking that evening. I feel much better today, Tuesday June 14, 2022.
patient came to pharmacy 2-3 hours after thier vaccine complaining of headache, nausea, and lightheadedness. gave the patient a water, instructed them to take a few deep breaths and gave them a cold compress to apply to their forehead. after 10 minutes patient was feeling fine and was driven home.
Had several episodes of heart palpitations; This is a spontaneous report from a non-contactable consumer, the patient. A 14-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had none known allergies to medications, food or other products. On an unknown date, second day after second dose, the patient had several episodes of heart palpitations, which ended after third day. There was no pain or shortness of breath. The event had resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event several episodes of heart palpitations was recovered on an unknown date, at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Dizziness, Headache, Myalgia, Arthralgia, injection site pain, fatigue, for 5 days Narrative:  used tylenol  Other Relevant History:
Itching at the injection site; Redness at the injection site; Bump at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included CLOPIDOGREL and CARVEDILOL for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included CLOPIDOGREL and CARVEDILOL for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Rectal bleeding; Stomach ache; Diarrhea; sick; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program Pfizer First Connect.  A 41-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK5730 and Expiration Date: 31Mar2021), via an unspecified route of administration in the right arm on 20Dec2020 at a single dose for COVID-19 immunization. The patient's medical history was reported as none. There were no concomitant medications. On 01Jan2021, the patient experienced: rectal bleeding, stomachache, diarrhea, sick; all assessed as medically significant. The clinical course was reported as follows: The patient received the first dose of the COVID-19 vaccine on 20Dec2020; as she was at high risk due to working with COVID patients in the hospital. The patient became sick on 01Jan2021. The patient experienced a stomach-ache, diarrhea, and rectal bleeding. When these events occurred, the patient went to the emergency room (ER). A doctor there prescribed the patient the antibiotics metronidazole 500 mg and cefdinir 300 mg. The patient was also scheduled to follow up with a gastrointestinal (GI) doctor. The patient called asking if she should get the second dose since she was taking antibiotics. The patient was scheduled for the second dose on 08Jan2020.The patient reported she had improved. The symptoms, at the time of the report, were not that bad. Therapeutic measures were taken as a result of rectal bleeding, stomachache, diarrhea, and sick. The clinical outcome of the events was recovering.
Pt was seated and suddenly became flushed and reported a strange taste in her mouth. Vitals taken. BP 116/65, pulse 87, O2 99%. Pt given water and continued to observe. Pt reported feeling better.
During the night after the vaccine, the patient woke up in the middle of the night not feeling well. He says he remembers walking to the bathroom, didn't know where he was or what he was doing, and kind of "blacked out". He said he fell into the door but caught himself so he didn't fall to the ground. He says now he feels like he has "long covid" complaining of fatigue and brain fog
pt exp weakness late  @ noc until following date, referred to hosp d/t significant weakness;
Patient got a fever and a red mark from vaccine. We monitored and by 6pm the following day she had large bruise with red and yellow along site of vaccinations. We called on call doctor and were told to go to urgent care. On 2/23/17 patient was seen at Urgent Care. The doctor just prescribed allergy medicine and topical ointment and follow up with primary. On 2/24/17 patient was seen at primary care. The site where shot was given was hot to touch and she was in pain while moving leg. Her leg was infected at vaccination site. She was prescribed antibiotic. She still has large discolored area and pending follow up appointment at this time.
Injection on  Wednesday at 3 PM. No immediate reaction. However, a few hours after the shot my left arm (at the injection site) was sore and swollen.  That evening it was painful and disrupted my sleep. The next morning (Thursday) I was somewhat feverish. By the mid-morning my fever was up to 100.4, and by the late afternoon it was up to 101.4. I felt exhausted -- too exhausted to even write an email. I had chills, backache,  and slept nearly the entire day (~8 hours). Based on this, I would call this day a 4 in terms of severity.   The next day (Friday), my fever had declined to 100.2 but was still elevated, but now I had a backache (lower back), and I was still weak. However, I could get out of bed for about 10 minutes without too much difficulty. I slept for about 5 hours during the day. This may also qualify as a 4.  On Saturday, my fever had declined further to 99.4, and my energy level was somewhat better.  Even so, most of the day was spent in bed, but I slept less during the day than on the previous days (about 3 hours). The main thing that was a problem on Saturday besides being weak was a headache. This is a strange thing because I rarely have had headaches in my life.  This is a pounding in the front of my head, only occurring when going from an upright position into a seated or supine position. Most of the headache disappears in about 30 seconds.  Overall I would say Saturday was a 3 in terms of severity. Today (Sunday) my temperature seems to be normal (98.6) -- though this is a full degree above what is normal for me. However, the headache has become worse -- it was hurting me while sleeping, and woke me up from the discomfort.  I still have the backache, and I am still weak. It's only 6 AM here so I cannot comment on how the rest of the day will go.
Information has been received from a medical assistant concerning unspecified patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unspecified dates since 29-SEP-2016, the patients received doses of improperly stored ROTATEQ orally (lot # M007124, expiration date 05-OCT-2017) (dose and frequency was not reported. The vaccines were stored at 31.6 F for 30 minutes. The temperature excursions were detected by a "data logger". There was no previous temperature excursion. The medical assistant was not aware of any adverse effects. This is one of several reports received from the same reporter. Additional information has been requested.
Same day fatigue 3/2 3/3 fatigue and in the evening chills and fever of 100.8 By the evening of 3/4, I felt fine. I stayed home, napped and rested. Drank water. Took Tylenol the 2nd night for fever.
Also have had neck pain since the first vaccine that will not go away; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 13:00 (Batch/Lot number: unknown) at the age of 33 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: METHYLPHENIDATE. The following information was reported: NECK PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Also have had neck pain since the first vaccine that will not go away". The event "also have had neck pain since the first vaccine that will not go away" was evaluated at the physician office visit. Therapeutic measures were taken as a result of neck pain. Additional information: Patient was not administered with other vaccine in four weeks. 3 weeks after the final vaccination, despite being active and healthy - I experienced suddenly extreme pain in my left leg and was unable to walk on it. doctors found a superficial blood clot. Also have had neck pain since the first vaccine that will not go away. Patient was not tested covid prior vaccination and post vaccination. No known allergies:  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021523842 same patient/drug, different dose/event
Injection placed in wrong area of arm-too high; Incorrect dosage; Bruised left arm; pain at injection site left arm; Bleeding left arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bleeding left arm), PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection placed in wrong area of arm-too high), UNDERDOSE (Incorrect dosage), VACCINATION SITE BRUISING (Bruised left arm) and VACCINATION SITE PAIN (pain at injection site left arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C217 and 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bleeding left arm). On 19-May-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection placed in wrong area of arm-too high), UNDERDOSE (Incorrect dosage), VACCINATION SITE BRUISING (Bruised left arm) and VACCINATION SITE PAIN (pain at injection site left arm). On 22-Apr-2021, VACCINATION SITE HAEMORRHAGE (Bleeding left arm) had resolved. At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection placed in wrong area of arm-too high), UNDERDOSE (Incorrect dosage), VACCINATION SITE BRUISING (Bruised left arm) and VACCINATION SITE PAIN (pain at injection site left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.  Based on the current available information and temporal association between the 1st dose of mRNA-1273 (lot #009C21A) and  start date of the event of vaccination site bleeding, a causal relationship cannot be excluded. Additionally, vaccine underdose and administered at inappropriate site were reported for second dose of  mRNA-1273 (lot # 003C217) with associated adverse events of vaccination site bruising and vaccination site pain, assessed as possibly related due to temporal association.; Sender's Comments: Based on the current available information and temporal association between the 1st dose of mRNA-1273 (lot #009C21A) and  start date of the event of vaccination site bleeding, a causal relationship cannot be excluded. Additionally, vaccine underdose and administered at inappropriate site were reported for second dose of  mRNA-1273 (lot # 003C217) with associated adverse events of vaccination site bruising and vaccination site pain, assessed as possibly related due to temporal association.
Flushing erythematous macular rash over neck and upper torso, pt felt warm and flushed  No treatment, 30min observation   Rash was not improved or worsening after 30 min, pt was released with ER precaution
First I had the itching and I came home and took a Benadryl and it subsided. The next day, I woke up stiff as a board. Everything hurt. Like I remember having the flu - feeling you get when joints etc. hurts all over. I took Tylenol - maybe took 1000 mg twice in that day. I have fibromyalgia and this was over and above that. The third day, the injection site on arm really hurt. The fourth or fifth day, the cough started - first a little irritation and then I started coughing and rattling and I have had the cough ever since. I have seen my doctor four times in the last month to get medications that work. I had to go to the walk in (Urgent Care at the clinic on Weekends) this Saturday  (5/15/2021) and get this new medication that seems to be working - it's a steroid - it's Levaquin . Although, yesterday, I still had that overall body hurt (I was in bed all day) - could have been side affect of medication but today (after two doses) seems to be better and I'm not coughing as much.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 at 18:00 as dose 4 (booster), single (Lot number: GH9703) at the age of 34 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "depression" (unspecified if ongoing); "endometriosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course details: Patient had no known allergies. Patient was treated with Paxlovid from 01Aug2023 to 05Aug2023 for COVID-19.  No follow-up attempts are possible. No further information is expected.
About a week after my first shot, the middle joint of my fifth finger on my left had became sore, especially upon touch. It also stiffined. About a week after my second shot, the middle joint of my fourth finger became sore, especially upon pressure and is somewhat stiff. I have no history of any type of arthritis nor is it in my family. I had no problems with my fingers on either hand prior to the vaccinations. I play piano and never had any pains nor stiffness.
Headache; This is a spontaneous report from a contactable consumer (Patient). A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899, reported as BioNTech SARS-CoV-2) on right arm at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient stated a side effect to the vaccine (BioNTech SARS-CoV-2), she was just having the headache that won't go away. Treatment: consumer stated just took some over the counter Aspirin. Outcome of the event was not recovered.  Follow-up attempts have been completed and no further information is expected
very dark urine; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (very dark urine) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 immunisation.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHROMATURIA (very dark urine). On 18-Feb-2021, CHROMATURIA (very dark urine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Tachycardia; shortness of breath; rigors; muscle pain; fatigue; headache; This is a spontaneous report from a Contactable consumer (patient).  A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=Fl3249), via an unspecified route of administration in left arm on 19Jan2021 13:00 at first single dose for COVID-19 immunization. Medical history included high cholesterol, gastrooesophageal reflux disease (GERD), dry eye syndrome, covid-19 (covid prior vaccination). Known allergies: No. Concomitant medication included atorvastatin, fish oil, pantoprazole. No other vaccine received in four weeks. The patient experienced tachycardia, shortness of breath, rigors, muscle pain, fatigue, headache, on 20Jan2021 02:30 AM. Events resulted in: Emergency room/department or urgent care. Events treatment inluded: Fluids, tylenol, clonazepam. Covid was not tested post vaccination. Outcome of the events was recovering.
2 shots were given in each leg. His right leg became swollen a short time after getting home. By 9:00 PM he complained about the pain. Around 3:00AM he cried for me to come help him to the bathroom. He couldn't walk. He was trying to crawl to the bathroom but was in too much pain. Today it is 3:20 PM 05/06/2010, the pain is still there, he cannot walk due to the pain. He about screams when you barely touch his leg without applying any pressure. He has a fever.  He has a hard time even adjusting his leg when he's sitting back on the couch. He still has to be carried to the bathroom. The sight of the shot is not red, no pus. It's swollen, normal color.... extremely painful for him. Doctors office said to just ice it, and give Motrin IB for kids.
Pt vaccinated with DT/MMR developed swelling (extreme), erythema & pain around site of infection. Fever 99.4, arthralgias.